The Motley Fool•7 Kasım 2026Eli Lilly raises 2026 revenue guidance to $92 billion on strong GLP-1 drug sales
CNBC•5 Kasım 2026Jim Cramer's trust takes profits in Cardinal Health and Eli Lilly after strong rally
The Motley Fool•31 Ekim 2026Billionaire investors increased stakes in Alphabet and Eli Lilly in Q2 2026